{"id":"https://openalex.org/W2014644687","doi":"https://doi.org/10.1080/13556210020040235","title":"Salivary cortisol during opiate dependence and withdrawal","display_name":"Salivary cortisol during opiate dependence and withdrawal","alternate_titles":[],"publication_year":2001,"publication_date":"2001-04-01","ids":{"openalex":"https://openalex.org/W2014644687","doi":"https://doi.org/10.1080/13556210020040235","mag":"2014644687","pmid":"https://pubmed.ncbi.nlm.nih.gov/11341855"},"language":"en","primary_location":{"id":"doi:10.1080/13556210020040235","doi":"https://doi.org/10.1080/13556210020040235","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13556210020040235","pdf_url":null,"source":{"id":"https://openalex.org/S118332200","display_name":"Addiction Biology","issn_l":"1355-6215","issn":["1355-6215","1369-1600"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction Biology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2014644687"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111877439","display_name":"Jenny Bearn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. Bearn","raw_affiliation_strings":["National Addiction Centre, Institute of Psychiatry, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Addiction Centre, Institute of Psychiatry, London","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005911461","display_name":"Neena Buntwal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N. Buntwal","raw_affiliation_strings":["National Addiction Centre, Institute of Psychiatry, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Addiction Centre, Institute of Psychiatry, London","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001507058","display_name":"A. Papadopoulos","orcid":"https://orcid.org/0000-0002-8034-879X","observed_orcids":["https://orcid.org/0000-0002-8034-879X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Papadopoulos","raw_affiliation_strings":["Affective Disorders Unit, Institute of Psychiatry, De Crespigny Park, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affective Disorders Unit, Institute of Psychiatry, De Crespigny Park, London, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"S. Checkley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Checkley","raw_affiliation_strings":["Affective Disorders Unit, Institute of Psychiatry, De Crespigny Park, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affective Disorders Unit, Institute of Psychiatry, De Crespigny Park, London, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111877439"],"corresponding_institution_ids":[],"apc_list":{"value":3150,"currency":"USD","value_usd":3150},"apc_paid":null,"fwci":0.7048,"has_fulltext":false,"cited_by_count":46,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.57520325,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"6","issue":"2","first_page":"157","last_page":"162"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.6528000235557556,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.6528000235557556,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.26170000433921814,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.03310000151395798,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/salivary-cortisol","display_name":"salivary cortisol","score":0.9879999756813049},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9660000205039978},{"id":"https://openalex.org/keywords/opioid-withdrawal","display_name":"opioid withdrawal","score":0.9639999866485596},{"id":"https://openalex.org/keywords/lofexidine","display_name":"lofexidine","score":0.9259999990463257},{"id":"https://openalex.org/keywords/detoxification","display_name":"detoxification","score":0.5720000267028809},{"id":"https://openalex.org/keywords/hypothalamic-pituitary-adrenal-axis","display_name":"hypothalamic-pituitary-adrenal axis","score":0.9129999876022339},{"id":"https://openalex.org/keywords/withdrawal-symptom-severity","display_name":"withdrawal symptom severity","score":0.8870000243186951},{"id":"https://openalex.org/keywords/relapse-vulnerability","display_name":"relapse vulnerability","score":0.8820000290870667},{"id":"https://openalex.org/keywords/abstinence","display_name":"abstinence","score":0.6069999933242798}],"concepts":[{"id":"https://openalex.org/C121929971","wikidata":"https://www.wikidata.org/wiki/Q7227004","display_name":"Polysubstance dependence","level":3,"score":0.7862579822540283},{"id":"https://openalex.org/C504460877","wikidata":"https://www.wikidata.org/wiki/Q155925","display_name":"Saliva","level":2,"score":0.697257936000824},{"id":"https://openalex.org/C2780687700","wikidata":"https://www.wikidata.org/wiki/Q210978","display_name":"Abstinence","level":2,"score":0.6807679533958435},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6142570972442627},{"id":"https://openalex.org/C19720800","wikidata":"https://www.wikidata.org/wiki/Q7722","display_name":"Morning","level":2,"score":0.5732806921005249},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.5661649703979492},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48740604519844055},{"id":"https://openalex.org/C2778709874","wikidata":"https://www.wikidata.org/wiki/Q190875","display_name":"Hydrocortisone","level":2,"score":0.4552236795425415},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4541960060596466},{"id":"https://openalex.org/C62913699","wikidata":"https://www.wikidata.org/wiki/Q5173333","display_name":"Cortisol awakening response","level":3,"score":0.43733155727386475},{"id":"https://openalex.org/C2778062832","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Drug withdrawal","level":3,"score":0.4270777106285095},{"id":"https://openalex.org/C2780841215","wikidata":"https://www.wikidata.org/wiki/Q422549","display_name":"Glucocorticoid","level":2,"score":0.42247438430786133},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.39047494530677795},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.24788501858711243},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.17090532183647156},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.16435489058494568},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1080/13556210020040235","doi":"https://doi.org/10.1080/13556210020040235","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13556210020040235","pdf_url":null,"source":{"id":"https://openalex.org/S118332200","display_name":"Addiction Biology","issn_l":"1355-6215","issn":["1355-6215","1369-1600"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction Biology","raw_type":"journal-article"},{"id":"pmid:11341855","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11341855","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction biology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W10094436","https://openalex.org/W1967477824","https://openalex.org/W1976889710","https://openalex.org/W1981011616","https://openalex.org/W1986331833","https://openalex.org/W2002804723","https://openalex.org/W2005061399","https://openalex.org/W2018514933","https://openalex.org/W2027324007","https://openalex.org/W2032451423","https://openalex.org/W2034202363","https://openalex.org/W2065915319","https://openalex.org/W2067594932","https://openalex.org/W2087389654","https://openalex.org/W2087917230","https://openalex.org/W2089268269","https://openalex.org/W2125122458","https://openalex.org/W2133147770","https://openalex.org/W2176056137","https://openalex.org/W2258402131","https://openalex.org/W2311776902","https://openalex.org/W7008248533"],"related_works":["https://openalex.org/W2044584771","https://openalex.org/W2027324007","https://openalex.org/W2158239848","https://openalex.org/W1997123099","https://openalex.org/W2045060980","https://openalex.org/W2790086135","https://openalex.org/W2048524200","https://openalex.org/W3184403790","https://openalex.org/W2040180913","https://openalex.org/W2084186904"],"abstract_inverted_index":{"Seventeen":[0],"inpatients":[1],"(14":[2],"men,":[3],"three":[4],"women)":[5],"with":[6,46,102],"opiate":[7,28,130],"dependence":[8],"and":[9,22,31,68],"polysubstance":[10],"misuse":[11],"participated":[12],"in":[13,59,129,141],"a":[14,47,79,93,123],"longitudinal":[15],"study":[16,121],"of":[17,50,73,81,95,117,134,137],"salivary":[18,32],"cortisol":[19,33,76,98,107],"secretion":[20],"during":[21,90],"after":[23,149],"lofexidine":[24],"detoxification":[25],"treatment.":[26,74],"Both":[27],"withdrawal":[29,60,103],"symptoms":[30],"were":[34,44],"measured":[35],"every":[36],"morning":[37],"for":[38,114,125,147],"up":[39],"to":[40,87,144],"25":[41],"days.":[42],"Results":[43],"compared":[45],"control":[48],"group":[49],"10":[51],"normal":[52],"volunteers.":[53],"There":[54],"was":[55],"an":[56],"80%":[57],"reduction":[58,94],"symptom":[61,104],"severity":[62],"between":[63],"the":[64,69,115,118,138,145],"first":[65],"12":[66,71],"days":[67,72,85,91],"subsequent":[70],"Salivary":[75,97,106],"fell":[77],"from":[78],"mean":[80],"22.3":[82],"nm/l":[83,89],"over":[84],"1-12":[86],"18.5":[88],"13-25,":[92],"17%.":[96],"concentration":[99],"correlated":[100],"significantly":[101,110],"severity.":[105],"levels":[108],"remained":[109],"higher":[111],"than":[112],"controls":[113],"duration":[116],"study.":[119],"The":[120,132],"supports":[122],"role":[124],"hypothalamo-pituitary-adrenal":[126],"(HPA)":[127],"activation":[128],"withdrawal.":[131],"contribution":[133],"persistant":[135],"dysregulation":[136],"HPA,":[139],"found":[140],"this":[142],"study,":[143],"vulnerability":[146],"relapse":[148],"abstinence":[150],"has":[151],"been":[152],"achieved,":[153],"is":[154],"discussed.":[155]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2014644687","counts_by_year":[{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
